Literature DB >> 26713335

The Implications of the Sequestosome 1 Mutation P392L in Patients with Paget's Disease in a United States Cohort.

Margaret Seton1, Marc Hansen2, Daniel H Solomon3.   

Abstract

Paget's disease of bone (PDB) is associated with a germline mutation in Sequestosome1/p62 (SQSTM1) found in ≤16 % of sporadic cases worldwide, and in 19-46 % of those studied with familial PDB. The P392L is the most prevalent mutation identified to date. This mutation by itself does not confer PDB or define the phenotype of PDB in a given person. Environmental determinants remain elusive, although increasing age of the individual, other gene polymorphisms in the context of SQSTM1 mutations, and measles virus have been implicated. Measles exposure has been unexamined in this context. The goal of this study is to compare the background history and phenotype of patients with PDB carrying the SQSTM1 P392L mutation to those patients without. Focusing on age, ancestry, P329L mutation, family history, measles exposure, distribution of PDB, and age of onset, we examined outcomes at 10 years. We postulated that aging may play a role in defining phenotype, and that this may become more visible in a well-characterized cohort. This is an observational study focused on a cohort of patients with PDB drawn from the New England Registry in whom environmental and family history has been catalogued, linked to radiographic data. Of the 217 persons who were enrolled in the Registry, 42 (19 %) responded to a letter inviting them to participate in testing for the presence of the measles antibody, and in genetic testing for the P392L mutation. The mean age of the cohort in 2001 was 70 years (range 55-79); 27 were men (64 %). The measles antibody was found in all cases tested. Nine patients had the P392L mutation (21 %), 2 with familial PDB. In these persons, early diagnosis of disease and spinal stenosis marked the male phenotype only. European ancestry was noted in the minority of those with P392L mutation. Most deaths recorded occurred in the ninth decade of life or later. Spinal stenosis emerges as a prominent phenotype in SQSTM1 P392L-positive men with aging. In these 42 patients with PDB from the New England Registry, most do not carry the SQSTM1 P392L mutation, and many do not have European ancestry. Exposure to measles was confirmed in the majority.

Entities:  

Keywords:  Observational study; Paget’s disease of bone; SQSTM1

Mesh:

Substances:

Year:  2015        PMID: 26713335      PMCID: PMC4847721          DOI: 10.1007/s00223-015-0103-5

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  22 in total

1.  Prevalence of pelvic Paget's disease of bone in the United States.

Authors:  R D Altman; D A Bloch; M C Hochberg; W A Murphy
Journal:  J Bone Miner Res       Date:  2000-03       Impact factor: 6.741

2.  Paget's disease of bone in New Zealand: continued decline in disease severity.

Authors:  H R Cundy; G Gamble; D Wattie; M Rutland; T Cundy
Journal:  Calcif Tissue Int       Date:  2004-10-07       Impact factor: 4.333

3.  Evidence for increased clinical severity of familial and sporadic Paget's disease of bone in Campania, southern Italy.

Authors:  Domenico Rendina; Luigi Gennari; Gianpaolo De Filippo; Daniela Merlotti; Enrico de Campora; Flavio Fazioli; Gioacchino Scarano; Ranuccio Nuti; Pasquale Strazzullo; Giuseppe Mossetti
Journal:  J Bone Miner Res       Date:  2006-12       Impact factor: 6.741

4.  Sequestosome 1: mutation frequencies, haplotypes, and phenotypes in familial Paget's disease of bone.

Authors:  Jean Morissette; Nancy Laurin; Jacques P Brown
Journal:  J Bone Miner Res       Date:  2006-12       Impact factor: 6.741

5.  European distribution of Paget's disease of bone.

Authors:  F M Detheridge; P B Guyer; D J Barker
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-09

6.  Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone.

Authors:  Nancy Laurin; Jacques P Brown; Jean Morissette; Vincent Raymond
Journal:  Am J Hum Genet       Date:  2002-04-30       Impact factor: 11.025

7.  Incidence and natural history of Paget's disease of bone in England and Wales.

Authors:  T P van Staa; P Selby; H G M Leufkens; K Lyles; J M Sprafka; C Cooper
Journal:  J Bone Miner Res       Date:  2002-03       Impact factor: 6.741

8.  Ubiquitin-associated domain mutations of SQSTM1 in Paget's disease of bone: evidence for a founder effect in patients of British descent.

Authors:  Gavin J A Lucas; Lynne J Hocking; Anna Daroszewska; Tim Cundy; Geoff C Nicholson; John P Walsh; William D Fraser; Christian Meier; Michael J Hooper; Stuart H Ralston
Journal:  J Bone Miner Res       Date:  2004-11-16       Impact factor: 6.741

9.  Familial Paget's disease in The Netherlands: occurrence, identification of new mutations in the sequestosome 1 gene, and their clinical associations.

Authors:  E W M Eekhoff; M Karperien; D Houtsma; A H Zwinderman; C Dragoiescu; A L J Kneppers; S E Papapoulos
Journal:  Arthritis Rheum       Date:  2004-05

10.  Expression of measles virus nucleocapsid protein in osteoclasts induces Paget's disease-like bone lesions in mice.

Authors:  Noriyoshi Kurihara; Hua Zhou; Sakamuri V Reddy; Veronica Garcia Palacios; Mark A Subler; David W Dempster; Jolene J Windle; G David Roodman
Journal:  J Bone Miner Res       Date:  2005-11-21       Impact factor: 6.741

View more
  3 in total

1.  A FKBP5 mutation is associated with Paget's disease of bone and enhances osteoclastogenesis.

Authors:  Bingru Lu; Yulian Jiao; Yinchang Wang; Jing Dong; Muyun Wei; Bin Cui; Yafang Sun; Laicheng Wang; Bingchang Zhang; Zijiang Chen; Yueran Zhao
Journal:  Exp Mol Med       Date:  2017-05-19       Impact factor: 8.718

Review 2.  Selective Autophagy Receptor p62/SQSTM1, a Pivotal Player in Stress and Aging.

Authors:  Anita V Kumar; Joslyn Mills; Louis R Lapierre
Journal:  Front Cell Dev Biol       Date:  2022-02-14

3.  Clinical Characteristics and Pathogenic Gene Identification in Chinese Patients With Paget's Disease of Bone.

Authors:  Xiaohui Tao; Li Liu; Xingguang Yang; Zhe Wei; Zhongzhong Chen; Ge Zhang; Zhenlin Zhang; Hua Yue
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-09       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.